Yahoo France Recherche Web

Résultats de recherche

  1. Il y a 2 jours · Psyence Biomedical Ltd. engages in the development of natural psilocybin products for the healing of psychological trauma and mental health consequences in the context of palliative care.

    • US$0.51
    • US$14.55
    • 0.18
  2. Il y a 5 jours · See the latest Psyence Biomedical Ltd stock price (PBM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

    • 0.41
    • 0.38
    • −152.14
  3. Il y a 4 jours · Psyence Biomedical Ltd. is a life science biotechnology company. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context...

  4. Il y a 4 jours · Stock analysis for Psyence Biomedical Ltd (PBM:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

  5. Il y a 1 jour · Stock analysis for Psyence Group Inc (PSYG:Canadian Sec) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

  6. Il y a 4 jours · Psyence Therapeutics develops natural psilocybin products, medicinal formulations and treatment protocols to treat mental health disorders in a clinical environment. Psyence Production operates...

  7. Il y a 5 jours · Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (" Psyence " or the " Company "), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is delighted to announce that it has received approval for its Phase IIa clinical trial from the Medicines and Healthcare products Regulatory ...